NRIX 8-K 2026-10-13

Nurix Therapeutics, Inc. (NRIX) 8-K dated 2026-10-13 — accession 0001549595-26-000048. This URL is the filing, not the NRIX hub.

Nurix Therapeutics, Inc. (NRIX) is a biotechnology company listed on NASDAQ.

NRIX: SECURITIES AND EXCHANGE COMMISSION

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NRIX revenue for 2025-11-30 was $84.0M. Net income was -$264.5M. Revenue was up 54.0% from 2024-11-30 to 2025-11-30. NRIX currently screens at market cap $1.77B.

Not investment advice. The NRIX SEC hub lists recent forms. The stock page is the research view.